COVID-19 treatment | Gilead to begin clinical trials of inhaled version of remdesivir

COVID-19 treatment | Gilead to begin clinical trials of inhaled version of remdesivir Gilead Sciences says it also expects to supply remdesivir to treat more than two million COVID-19 patients by year-end.

No comments:

Post a Comment